Neoventa Medical AB is a Swedish company that makes fetal monitoring devices, including the Stan S41 for labor.
Founded in Molndal, Sweden, Neoventa Medical AB develops fetal monitoring technologies, led by its Stan S41 continuous monitoring device, which combines ST segment analysis with ECG monitoring. Its products serve hospitals and clinics across Europe, the Middle East, Asia and Africa. On June 19, 2006 the company raised SEK 75 million from Patricia Industries, Russia Growth, and SEB Venture Capital. In 2022 it reported revenue of SEK 6,788,561.90 and an EBITDA of SEK 392,900.70, and it is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in